Login to Your Account

Earnings Roundup

Thursday, November 1, 2012

• Acorda Therapeutics Inc., of Ardsley, N.Y., beat analyst estimates for the third quarter, posting GAAP net income of $9.6 million, or 24 cents per share, well above consensus estimates of 10 cents per share.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription